Keryx (KERX) Zerenex PDUFA Date Extension No Surprise; H.C. Wainwright Reiterates Buy
Tweet Send to a Friend
H.C. Wainwright maintained a Buy rating on Keryx Biopharmaceuticals (NASDAQ: KERX) with a price target of $19.00. The stock was ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
